5th meeting of the ACNFP and COT Joint Subgroup on CBD and Hemp Derived Products Agenda 8th March 2023

CBD05/2023

Joint Subgroup of the Advisory Committee on Novel Foods and Processes (ACNFP) and Committee on Toxicity (COT) on CBD and Hemp Derived Products

Pure form CBD position paper and CBG literature review

The 5th meeting of the ACNFP/COT CBD Subcommittee will be held at 10:00pm on the 8th of March 2023 on Microsoft Teams (online & dial in) as we ease out of the Coronavirus pandemic.

Members are reminded of the need to announce any commercial interests in the business of the Committee prior to the discussions on each item.

In accordance with agreed procedures, the Secretariat is duty bound to keep a record of the names of Members who have declared interests at meetings of the Committee, giving dates, names of relevant products and companies, details of the interest declared, and whether the Member took part in the proceedings.

ACNFP/COT Secretariat

March 2023

1. Apologies and Announcements.

2. Welcome and Introductions.

3. Minutes from the previous meeting – The Secretariat and Subcommittee will discuss the availability and the future review of the minutes from January 2023.

4. Pure form CBD position paper - the subcommittee will review and provide commentary to the FSA on a final draft which concerns the updated advice for pure form CBD. CBD05/2023/01

5. CBG/CBN literature review discussion– The Secretariat will discuss a literature review concerning CBG and other cannabinoids for the first time. CBD05/2023/02

6. AOB

7. Date of next meeting – Wednesday 3rd May 2023 – Microsoft Teams.